Editor's Choice

Doctors and the drug industry

BMJ 2008; 336 doi: 10.1136/bmj.39444.472708.47 (Published 3 January 2008)
Cite this as: BMJ 2008;336:7634

This article has a correction

Please see: Editor’s Choice: Doctors and the drug industry

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Fiona Godlee, editor
  1. fgodlee{at}bmj.com

    The Royal College of Physicians is looking at relations between doctors and the drug industry and wants to hear from you (doi: 10.1136/bmj.39428.617431.DB). In case you need them, here are some pointers from this week’s BMJ.

    Firstly, should we fear for the integrity of medical research because clinical trials are overwhelmingly funded by industry? Yes, says Paulo Bruzzi (doi 10.1136/bmj.39416.559942.BE). Industry designs trials mainly to get new drugs registered as soon as possible, preferably with an unrestricted indication. The best trials for this—in large unselected populations—often leave key questions unanswered and, because of ethical constraints on subsequent trials, unanswerable.

    Bruzzi is only …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular